Folgen
Mark Robertson-Tessi
Mark Robertson-Tessi
Bestätigte E-Mail-Adresse bei moffitt.org - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Impact of metabolic heterogeneity on tumor growth, invasion, and treatment outcomes
M Robertson-Tessi, RJ Gillies, RA Gatenby, ARA Anderson
Cancer research 75 (8), 1567-1579, 2015
2382015
A mathematical model of tumor–immune interactions
M Robertson-Tessi, A El-Kareh, A Goriely
Journal of theoretical biology 294, 56-73, 2012
1352012
Defining Cancer Subpopulations by Adaptive Strategies Rather Than Molecular Properties Provides Novel Insights into Intratumoral EvolutionModulating the Evolutionary Trajectory …
A Ibrahim-Hashim, M Robertson-Tessi, PM Enriquez-Navas, M Damaghi, ...
Cancer research 77 (9), 2242-2254, 2017
1012017
Abscopal Benefits of Localized Radiotherapy Depend on Activated T-cell Trafficking and Distribution between Metastatic LesionsT-cell Trafficking in Abscopal Response
JT Poleszczuk, KA Luddy, S Prokopiou, M Robertson-Tessi, EG Moros, ...
Cancer research 76 (5), 1009-1018, 2016
962016
Elastic growth models
A Goriely, M Robertson-Tessi, M Tabor, R Vandiver
Mathematical modelling of biosystems, 1-44, 2008
79*2008
Acidity promotes tumour progression by altering macrophage phenotype in prostate cancer
A El-Kenawi, C Gatenbee, M Robertson-Tessi, R Bravo, J Dhillon, ...
British journal of cancer 121 (7), 556-566, 2019
682019
Evolutionary dynamics of neoantigens in growing tumors
E Lakatos, MJ Williams, RO Schenck, WCH Cross, J Househam, L Zapata, ...
Nature genetics 52 (10), 1057-1066, 2020
482020
Hybrid Automata Library: A flexible platform for hybrid modeling with real-time visualization
RR Bravo, E Baratchart, J West, RO Schenck, AK Miller, J Gallaher, ...
PLoS computational biology 16 (3), e1007635, 2020
39*2020
Stochasticity in the genotype-phenotype map: implications for the robustness and persistence of bet-hedging
D Nichol, M Robertson-Tessi, P Jeavons, ARA Anderson
Genetics 204 (4), 1523-1539, 2016
392016
The role of toll-like receptors in colorectal cancer progression: evidence for epithelial to leucocytic transition
KA Luddy, M Robertson-Tessi, NK Tafreshi, H Soliman, DL Morse
Frontiers in immunology 5, 429, 2014
372014
Turnover Modulates the Need for a Cost of Resistance in Adaptive TherapyTurnover Modulates Resistance Costs in Adaptive Therapy
MAR Strobl, J West, Y Viossat, M Damaghi, M Robertson-Tessi, JS Brown, ...
Cancer research 81 (4), 1135-1147, 2021
332021
The harsh microenvironment in early breast cancer selects for a Warburg phenotype
M Damaghi, J West, M Robertson-Tessi, L Xu, MC Ferrall-Fairbanks, ...
Proceedings of the National Academy of Sciences 118 (3), e2011342118, 2021
332021
Normal tissue architecture determines the evolutionary course of cancer
J West, RO Schenck, C Gatenbee, M Robertson-Tessi, ARA Anderson
Nature communications 12 (1), 1-9, 2021
29*2021
Recombination line versus forbidden line abundances in planetary nebulae
M Robertson-Tessi, DR Garnett
The Astrophysical Journal Supplement Series 157 (2), 371, 2005
282005
The immune checkpoint kick start: Optimization of neoadjuvant combination therapy using game theory
J West, M Robertson-Tessi, K Luddy, DS Park, DFK Williamson, ...
JCO clinical cancer informatics 3, 1-12, 2019
252019
A model for effects of adaptive immunity on tumor response to chemotherapy and chemoimmunotherapy
M Robertson-Tessi, A El-Kareh, A Goriely
Journal of theoretical biology 380, 569-584, 2015
252015
Big Bang and context-driven collapse
M Robertson-Tessi, ARA Anderson
Nature Genetics 47 (3), 196-197, 2015
232015
The Goldilocks Window of Personalized Chemotherapy: Getting the Immune Response Just RightThe Goldilocks Window of Personalized Chemotherapy
DS Park, M Robertson-Tessi, KA Luddy, PK Maini, MB Bonsall, ...
Cancer research 79 (20), 5302-5315, 2019
222019
Model genotype–phenotype mappings and the algorithmic structure of evolution
D Nichol, M Robertson-Tessi, ARA Anderson, P Jeavons
Journal of The Royal Society Interface 16 (160), 20190332, 2019
152019
Systematic screening of chemokines to identify candidates to model and create ectopic lymph node structures for cancer immunotherapy
Y Yagawa, M Robertson-Tessi, SL Zhou, ARA Anderson, JJ Mulé, ...
Scientific reports 7 (1), 1-16, 2017
132017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20